Similar articles for PMID: 21707580

Year	Number of Results
1990	1
1995	1
1997	1
1998	3
1999	1
2000	2
2001	8
2002	8
2003	5
2004	4
2005	5
2006	3
2007	1
2008	6
2009	6
2010	6
2011	4
2012	3
2013	2
2014	4
2015	7
2016	7
2017	14
2018	9
2019	9
2020	6
2021	12
2022	8
2023	2
2024	0

1

Genetic strategies for the treatment of sickle cell anaemia.

Mansilla-Soto J, Rivière I, Sadelain M. Mansilla-Soto J, et al. Br J Haematol. 2011 Sep;154(6):715-27. doi: 10.1111/j.1365-2141.2011.08773.x. Epub 2011 Jun 28. Br J Haematol. 2011. PMID: 21707580 Free article. Review.

2

Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.

Sadelain M. Sadelain M. Curr Opin Hematol. 2006 May;13(3):142-8. doi: 10.1097/01.moh.0000219658.57915.d4. Curr Opin Hematol. 2006. PMID: 16567956 Review.

3

Gene replacement therapy for sickle cell disease and other blood disorders.

Townes TM. Townes TM. Hematology Am Soc Hematol Educ Program. 2008:193-6. doi: 10.1182/asheducation-2008.1.193. Hematology Am Soc Hematol Educ Program. 2008. PMID: 19074080

4

Current status of globin gene therapy for the treatment of beta-thalassaemia.

Lisowski L, Sadelain M. Lisowski L, et al. Br J Haematol. 2008 May;141(3):335-45. doi: 10.1111/j.1365-2141.2008.07098.x. Br J Haematol. 2008. PMID: 18410569 Free article. Review.

5

Stem cell therapy for sickle cell disease: transplantation and gene therapy.

Walters MC. Walters MC. Hematology Am Soc Hematol Educ Program. 2005:66-73. doi: 10.1182/asheducation-2005.1.66. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304361

6

Correction of sickle cell disease in transgenic mouse models by gene therapy.

Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, Acharya SA, Ellis J, London IM, Eaves CJ, Humphries RK, Beuzard Y, Nagel RL, Leboulch P. Pawliuk R, et al. Science. 2001 Dec 14;294(5550):2368-71. doi: 10.1126/science.1065806. Science. 2001. PMID: 11743206

7

Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.

Urbinati F, Campo Fernandez B, Masiuk KE, Poletti V, Hollis RP, Koziol C, Kaufman ML, Brown D, Mavilio F, Kohn DB. Urbinati F, et al. Hum Gene Ther. 2018 Oct;29(10):1153-1166. doi: 10.1089/hum.2018.061. Hum Gene Ther. 2018. PMID: 30198339

8

Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.

Urbinati F, Hargrove PW, Geiger S, Romero Z, Wherley J, Kaufman ML, Hollis RP, Chambers CB, Persons DA, Kohn DB, Wilber A. Urbinati F, et al. Exp Hematol. 2015 May;43(5):346-351. doi: 10.1016/j.exphem.2015.01.009. Epub 2015 Feb 12. Exp Hematol. 2015. PMID: 25681747 Free PMC article.

9

Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.

Persons DA. Persons DA. Hematology Am Soc Hematol Educ Program. 2009:690-7. doi: 10.1182/asheducation-2009.1.690. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008255 Review.

10

Progress toward the genetic treatment of the beta-thalassemias.

Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I. Sadelain M, et al. Ann N Y Acad Sci. 2005;1054:78-91. doi: 10.1196/annals.1345.010. Ann N Y Acad Sci. 2005. PMID: 16339654 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year